BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Nature. 2021 Jul;595(7868):572-577. doi: 10.1038/s41586-021-03653-6. Epub 2021 May 27.
Nature. 2021.
PMID: 34044428
Clinical Trial.